EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a ...
Real-world use of a CSF circulating tumor cell assay in the diagnosis and management of leptomeningeal metastasis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Morning Overview on MSN
MIT researchers strip cancer of its sugar shield
Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...
Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback